Structure-Based Drug Design Targeting Topoisomerase II Alpha: Discovery of Potential Antitumor Xanthone Derivatives. [PDF]
Le TTH +7 more
europepmc +1 more source
Modeling rotational fluoroquinolone therapy as a novel treatment for ophthalmic MRSA infections. [PDF]
Storper A, Miller D, Huo X.
europepmc +1 more source
TORCphysics: a physical model of DNA-topology-controlled gene expression. [PDF]
Velasco-Berrelleza V +7 more
europepmc +1 more source
Novel <i>N</i>-4-(5-Amino-7-substituted-triazolotriazinepiperazin-1-yl) Norfloxacin Analogues Exhibit Potent and Selective Anticancer Activity via Topoisomerase Inhibition, Cell-Cycle Arrest, and Apoptosis in A 431 Skin Carcinoma Cells. [PDF]
El-Saghier AM +4 more
europepmc +1 more source
Vacuolization as a Novel Approach to Cancer Therapy
This review discusses the novel strategy of inducing vacuole formation in cancer cells using small molecules, that induce nonapoptotic cell death mechanisms, such as paraptosis, oncosis, autophagy, and methuosis, and its potential in overcoming resistance to apoptosis‐based cancer therapies.
Mariah Pasternak +9 more
wiley +1 more source
Sequencing antibody-drug conjugates in metastatic cancer (Review). [PDF]
Abdalla BA.
europepmc +1 more source
IMP‐1700 enhances the cytotoxic effect on bacteria in combination with either ciprofloxacin (CPX) or X‐ray. In noncancerous and tumor cells, combination treatments markedly reduce viability with radiosensitizing effects. Further studies are needed to clarify the mechanism underlying IMP‐1700s effects on mammalian cells. Created in BioRender. Kjaer, A. (
Ida Vang Andersen +7 more
wiley +1 more source
Antibody-Drug Conjugates: Pharmacotherapeutic Properties and Future Perspectives. [PDF]
Augusto A, Cristiano MLS, Conceição J.
europepmc +1 more source
Cycle‐synchronized CTGT therapy attenuates LVGLS decline and reduces CTRCD in breast cancer patients. This randomized, double‐blind, placebo‐controlled trial assessed whether cycle‐synchronized CTGT prevent CTRCD in 120 breast cancer patients receiving chemotherapy.
Xiaoling Liu +11 more
wiley +1 more source
Topoisomerase II binding protein 1-interacting checkpoint and replication regulator promotes lung adenocarcinoma proliferation by regulating myelocytomatosis oncogene signaling pathway. [PDF]
Zhao Y, Feng Y, Guo M, Li L.
europepmc +1 more source

